ABOUT EVENT
について
关于
Tentang
The World Companion Diagnostics & Liquid Biopsy Summit APAC is a comprehensive, industry-led, two-day forum dedicated to advancing biomarker development, liquid biopsy testing, and companion diagnostics.
Uniting leading biopharma, academia, and service and solution providers, this meeting promises to foster meaningful conversations and business partnerships around the industry’s latest developments, regulatory changes, and innovative strategies to accelerate patient access to precision therapies in the APAC region.
Your Reasons to Attend
参加する理由
参加的理由
Sebab untuk Hadir
Navigate rapidly evolving regulatory guidelines across the region to streamline approvals and enable greater patient access to precision therapeutics with insights from Bristol Myers Squibb, Kyowa Kirin & Johnson & Johnson
Overcome barriers to market access with robust precision medicine strategies from clinical trials to companion diagnostic launch and tactical partnership selection to fast-track global development and commercialization of drugs/diagnostics with insights from Bristol Myers Squibb, Daiichi Sankyo & Omico
Gain insights into how more sensitive and specific liquid biopsies are enabling earlier disease diagnosis and more effective response monitoring using ctDNA analysis as an early endpoint for optimized treatment regimes with insights from Johnson & Johnson, Fudan University & Takeda
Learn how novel technologies including digital pathology and machine learning can optimise patient selection with enhanced prescreening for clinical trials to improve patient experience and outcomes with insights from Sanofi
Discover how to more accurately stratify patients with robust clinical biomarker development to make impactful decisions during treatment for improved therapeutic outcomes with insights from Harbour BioMed & OBI Pharma
ACCESS THE FULL PROGRAM
Explore two days of sessions, the 16+ expert speaker faculty, 6+ hours of networking and more by downloading your copy of the event guide.
